鉴定病毒性心肌炎和扩张性心肌病之间的共同病原和免疫景观
相关实验视频
Updated: Jul 11, 2025

12:46
Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
Published on: August 17, 2022
2.6K
Zhe Lei1,2, Jianlei Cao1,2, Jiahe Wu1,2
1Department of Cardiology, Zhongnan Hospital of Wuhan University, No. 169 Donghu Road, Wuchang District, Wuhan, 430071, China.
ESC heart failure
|November 15, 2023
概括
病毒性心肌炎 (VMC) 可能导致扩张性心肌病 (DCM). 这项研究确定了BLC6,FOXO1和UBE2M作为驱动VMC到DCM进展的关键基因,提供了新的诊断和治疗见解.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 病毒性心肌炎 (VMC) 是扩张性心肌病 (DCM) 的已知危险因素.
- 连接VMC与DCM进展的精确分子机制尚未完全理解.
- 需要进一步的研究来阐明这些潜在的分子通路.
研究的目的:
- 研究驱动从VMC到DCM的进展的分子机制.
- 为了确定关键的基因和信号通路涉及VMC到DCM过渡.
- 用DCM为VMC的诊断和治疗提供潜在的目标.
主要方法:
- 从基因表达综合数据库中使用了mRNA微阵列数据集 (DCM的GSE57338,VMC的GSE1145).
- 采用加权基因共同表达网络分析 (WGCNA),蛋白质与蛋白质相互作用分析和外部数据集验证 (GSE35182).
- 进行了丰富分析和免疫透分析,以探索信号通路和免疫细胞协会.
主要成果:
- 鉴定了在"癌症转录错误调节"和"FoxO信号通路"等途径中丰富的交叉基因.
- 观察到与VMC (休息树突细胞,M0巨细胞) 和DCM (单细胞,CD8+ T细胞等) 相关的独特免疫细胞概况. ) 的情况.
- 确定BLC6,FOXO1和UBE2M作为负责从VMC向DCM进展的关键基因,在数据集GSE35182.2中得到验证.
结论:
- 确定了三个关键基因:BLC6,FOXO1和UBE2M,作为VMC向DCM进展的关键驱动因素.
- 这些发现为从VMC到DCM过渡的分子基础提供了新的见解.
- 鉴定出来的基因可以作为潜在的生物标志物或治疗点,用于患有DCM风险的VMC患者.
相关概念视频
Myocarditis I: Introduction
9
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
9
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Myocarditis III: Medical Management
7
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
7
Myocarditis II: Clinical Features and Diagnostic Tests
12
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Cardiomyopathy I: Introduction and Classification
14
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
14
Cardiomyopathy III: Hypertrophic Cardiomyopathy
15
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
15

